milrinone has been researched along with Patency of the Ductus Arteriosus in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Population pharmacokinetic modeling and simulations suggest a slow loading dose followed by maintenance infusion to reach therapeutic milrinone plasma concentrations within the timeframe of the postligation cardiac syndrome." | 3.91 | Population Pharmacokinetics and Dosing of Milrinone After Patent Ductus Arteriosus Ligation in Preterm Infants. ( Hallik, M; Ilmoja, ML; Jalas, T; Kipper, K; Metsvaht, T; Raidmäe, M; Standing, JF; Starkopf, J; Takkis, K; Tasa, T; Uibo, K; Veigure, R, 2019) |
| " The differential effects of these PDE 3 inhibitors on the near-term and preterm ductus were studied by injecting indomethacin (10 mg/kg) and PDE 3 inhibitors into 21D (21st day of pregnancy: term-21." | 3.73 | In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. ( Imamura, S; Momma, K; Nakanishi, T; Toyoshima, K, 2006) |
| "Milrinone is administered after patent ductus arteriosus (PDA) ligation to prevent and treat postoperative hemodynamic instability (i." | 1.91 | Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study. ( Fujita, A; Ito, A; Kashima, K; Kato, M; Kitaoka, H; Konishi, T; Matsui, H; Shitara, Y; Takahashi, N; Yasunaga, H, 2023) |
| "Milrinone was initiated if LVO was < 200 mL/kg/min 1 h after surgery, to prevent PLCS." | 1.72 | Lung ultrasound score parallels trends in systemic haemodynamics after PDA ligation: a case series. ( Cattarossi, L; McNamara, PJ; Savoia, M; Titolo, A, 2022) |
| "Milrinone has been suggested as a possible first-line therapy for preterm neonates to prevent postligation cardiac syndrome (PLCS) through decreasing systemic vascular resistance and increasing cardiac contractility." | 1.46 | Dosing of Milrinone in Preterm Neonates to Prevent Postligation Cardiac Syndrome: Simulation Study Suggests Need for Bolus Infusion. ( Hallik, M; Metsvaht, T; Starkopf, J; Tasa, T, 2017) |
| "Hypotension is a common problem in neonates with complex underlying pathophysiology." | 1.46 | Management of Neonatal Hypotension. ( Kalish, BT, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Savoia, M | 1 |
| McNamara, PJ | 4 |
| Titolo, A | 1 |
| Cattarossi, L | 1 |
| Kitaoka, H | 1 |
| Konishi, T | 1 |
| Shitara, Y | 1 |
| Ito, A | 1 |
| Kashima, K | 1 |
| Fujita, A | 1 |
| Matsui, H | 1 |
| Kato, M | 1 |
| Takahashi, N | 1 |
| Yasunaga, H | 1 |
| Hallik, M | 2 |
| Ilmoja, ML | 1 |
| Tasa, T | 2 |
| Standing, JF | 1 |
| Takkis, K | 1 |
| Veigure, R | 1 |
| Kipper, K | 1 |
| Jalas, T | 1 |
| Raidmäe, M | 1 |
| Uibo, K | 1 |
| Starkopf, J | 2 |
| Metsvaht, T | 2 |
| EL-Khuffash, A | 2 |
| Lapointe, A | 1 |
| Jain, A | 3 |
| El-Khuffash, AF | 1 |
| Weisz, D | 1 |
| Mertens, L | 1 |
| Halliday, M | 1 |
| Kavarana, M | 1 |
| Ebeling, M | 1 |
| Kiger, J | 1 |
| Ting, JY | 1 |
| Resende, M | 1 |
| More, K | 1 |
| Nicholls, D | 1 |
| Weisz, DE | 1 |
| Kalish, BT | 1 |
| Sehgal, A | 1 |
| Francis, JV | 1 |
| Lewis, AI | 1 |
| Seri, I | 1 |
| Noori, S | 1 |
| Osborn, DA | 1 |
| Toyoshima, K | 1 |
| Momma, K | 1 |
| Imamura, S | 1 |
| Nakanishi, T | 1 |
2 reviews available for milrinone and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Diagnosis and treatment of neonatal hypotension outside the transitional period.
Topics: Adrenal Insufficiency; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, | 2005 |
Diagnosis and treatment of preterm transitional circulatory compromise.
Topics: Adrenal Cortex Hormones; Blood Circulation; Blood Pressure; Cardiac Output, Low; Dobutamine; Dopamin | 2005 |
11 other studies available for milrinone and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Lung ultrasound score parallels trends in systemic haemodynamics after PDA ligation: a case series.
Topics: Adult; Birth Weight; Ductus Arteriosus, Patent; Hemodynamics; Humans; Infant; Infant, Newborn; Infan | 2022 |
Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Enterocolitis, Necrotizi | 2023 |
Population Pharmacokinetics and Dosing of Milrinone After Patent Ductus Arteriosus Ligation in Preterm Infants.
Topics: Cardiotonic Agents; Ductus Arteriosus, Patent; Echocardiography; Female; Humans; Hypotension; Infant | 2019 |
Adrenal function in preterm infants undergoing patent ductus arteriosus ligation.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Cardiotonic Agents; Cohort Studies; Ductus Arter | 2013 |
Assessment and treatment of post patent ductus arteriosus ligation syndrome.
Topics: Cardiac Output; Cardiotonic Agents; Ductus Arteriosus, Patent; Echocardiography, Doppler; Elasticity | 2014 |
Milrinone use for hemodynamic instability in patent ductus arteriosus ligation.
Topics: Birth Weight; Chi-Square Distribution; Ductus Arteriosus, Patent; Gestational Age; Hemodynamics; Hum | 2017 |
Predictors of respiratory instability in neonates undergoing patient ductus arteriosus ligation after the introduction of targeted milrinone treatment.
Topics: Cardiac Surgical Procedures; Chi-Square Distribution; Ductus Arteriosus, Patent; Echocardiography, D | 2016 |
Dosing of Milrinone in Preterm Neonates to Prevent Postligation Cardiac Syndrome: Simulation Study Suggests Need for Bolus Infusion.
Topics: Cardiac Output; Cardiotonic Agents; Ductus Arteriosus, Patent; Estonia; Female; Gestational Age; Hum | 2017 |
Management of Neonatal Hypotension.
Topics: Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypoten | 2017 |
Use of milrinone in the management of haemodynamic instability following duct ligation.
Topics: Blood Pressure; Ductus Arteriosus, Patent; Heart; Hemodynamics; Humans; Infant, Newborn; Male; Milri | 2011 |
In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Animals, Newborn; Cyclic Nucleotide Phosphodiesterases | 2006 |